Dyadic International DYAI
NASDAQ DYAI
$0.48 -0.02 (-4.90%)
As of: Sep 10, 2026 · 3:29 PM EDT

Dyadic International (DYAI) Cash & Current Investments (2017 - 2026)

Dyadic International's (DYAI) quarterly Cash & Current Investments came in at $8.0 million in Q1 2026, up 8.32% year-over-year from $7.3 million in Q1 2025, and down 29.54% quarter-over-quarter from $11.3 million in Q4 2025.

Analysis

Dyadic International (DYAI) Cash & Current Investments (2017 - 2026) Analysis & Trends

Dyadic International has disclosed Cash & Current Investments across 10 years of filings, most recently posting $8.0 million for Q1 2026.

  • In Q1 2026, Cash & Current Investments rose 8.32% year-over-year to $8.0 million; the TTM figure through Mar 2026 stood at $8.0 million (up 8.32% YoY), while the FY2025 annual figure was $11.3 million, up 21.97% from the prior year.
  • Cash & Current Investments came in at $8.0 million for Q1 2026 at Dyadic International, down from $11.3 million in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $15.4 billion in Q1 2022 to a low of $7.3 million in Q4 2023.
  • Average Cash & Current Investments over 5 years is $918.6 million, with a median of $11.3 million recorded in 2025.
  • Year-over-year, Cash & Current Investments surged 56596.26% in 2022 and tumbled 99.92% in 2023.
  • Over 5 years, Cash & Current Investments stood at $12.6 million in 2022, then plunged by 42.54% to $7.3 million in 2023, then grew by 27.54% to $9.3 million in 2024, then gained by 21.97% to $11.3 million in 2025, then declined by 29.54% to $8.0 million in 2026.
  • Per Business Quant data, the three most recent Cash & Current Investments figures were $8.0 million in Q1 2026, $11.3 million in Q4 2025, and $13.5 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Amgen 206.69 Bn 192.70 Bn 7.24 Bn 13.99 Bn
2 Gilead Sciences 179.87 Bn 176.70 Bn 6.22 Bn 3.18 Bn
3 Vertex Pharmaceuticals 130.73 Bn 122.88 Bn 2.84 Bn 7.85 Bn
4 Regeneron Pharmaceuticals 81.70 Bn 73.71 Bn 3.93 Bn 7.99 Bn
5 Argenx Se 60.40 Bn 55.21 Bn 1.37 Bn 5.18 Bn
6 Moderna 54.28 Bn 49.14 Bn 52.00 Mn 5.14 Bn
7 Alnylam Pharmaceuticals 33.02 Bn 29.71 Bn 992.69 Mn 3.31 Bn
8 Biogen 31.93 Bn 30.64 Bn 1.96 Bn 1.29 Bn
9 Roivant Sciences 29.27 Bn 29.27 Bn 1.16 Mn -
10 Dyadic International 17.59 Mn 9.63 Mn - 7.96 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 7.96 Mn
Dec 31, 2025 11.30 Mn
Sep 30, 2025 13.50 Mn
Jun 30, 2025 14.20 Mn
Mar 31, 2025 7.35 Mn
Dec 31, 2024 9.26 Mn
Sep 30, 2024 9.92 Mn
Jun 30, 2024 10.10 Mn
Mar 31, 2024 12.04 Mn
Dec 31, 2023 7.26 Mn
Sep 30, 2023 8.18 Mn
Jun 30, 2023 10.13 Mn
Mar 31, 2023 11.74 Mn
Dec 31, 2022 12.64 Mn
Sep 30, 2022 14.20 Mn
Jun 30, 2022 15.64 Mn
Mar 31, 2022 15.44 Bn
Dec 31, 2021 20.26 Mn
Sep 30, 2021 22.75 Mn
Jun 30, 2021 25.60 Mn